Amgen | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
AbbVie USD 610M 19M 2024-12
Agios Pharmaceuticals 3.01M 10.05M 2024-12
ALKERMES USD 0 4.65M 2025-03
Amgen USD 723M 24M 2025-03
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Exelixis 23.4M 3.9M 2023-09
Genmab DKK 13M 2.67B 2025-03
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Glaxosmithkline 178.05M 24.73M 2024-12
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
J&J USD 128M 9M 2025-03
Merck USD 313M 15M 2025-03
Moderna USD 1000K 5M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 213M 151M 2025-03
Sarepta Therapeutics USD 4.92M 86K 2024-09
Takeda 50.32B 18.73B 2025-03
Teva Pharmaceutical Industries USD 212M 12M 2025-03
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Amgen Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.